Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITD
Target Price
The average target price of 1521.HK is 1.1 and suggests 3% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell